SOAT1 and posterior cortical atrophy: Inhibition of cholesteryl ester formation with avasimibe, a SOAT1 inhibitor initially developed for the treatment of atherosclerosis [4], in a cell culture model of PCa, was able to reduce the viability of the cells and to lower in vitro indicators of cell migration and invasiveness [5].